Download PDF
Semin Neurol 2024; 44(01): 026-035
DOI: 10.1055/s-0043-1777703
Review Article

Palliative Care in Neuro-oncology

Jessica M. Besbris
1   Cedars-Sinai Medical Center, Los Angeles, California
,
Lynne P. Taylor
2   Alvord Brain Tumor Center, Seattle, Washington
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Historically, the practice of neurology as an independent subspecialty from internal medicine began in Europe and the United States in the 1930s. The American Academy of Neurology (AAN) was founded 75 years ago in 1948, solidifying its emergence as a stand-alone discipline of medicine. In 1967, St. Christopher's Hospice, the first free standing hospice home, was opened in London by Dame Cicely Saunders. Dame Saunders is considered a pioneer in the development of the hospice movement, and she embodies the importance of the multi-disciplinary team in the care of the patient, as she began her career as a nurse, then became a social worker and, finally, a physician. A decade later, in 1978, Dr. Balfour Mount, a Canadian urologic cancer surgeon, coined the term “palliative care” (“to improve the quality of life”) after having spent time with Dr. Saunders at St. Christopher's some years earlier. The field of palliative care continued to develop as a distinct subspecialty focused on improving quality of life for patients at any age and in any stage of serious illness. In a 1996 position statement, the AAN made clear that the practice of primary palliative care is the responsibility of all neurologists to their patients. Finally, coming full circle, the specialty of neuro-palliative care, a subspecialty not just of neurology but of palliative medicine, became established around 2018. Neuro-palliative care can be seen as a specialty focusing on the holistic approach to symptom management in patients suffering from neurologic disease with the aim of improved symptom control and attention to the psychologic and spiritual aspects of illness.

Keywords

neuropalliative care - supportive care - palliative care


Publication History

Article published online:
04 January 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Koehler PJ. The founding of neurology as a specialty: the American situation in context. J Hist Neurosci 2018; 27 (03) 283-291
    CrossrefPubMedGoogle Scholar
  • 2 Saunders C. The evolution of palliative care. J R Soc Med 2001; 94 (09) 430-432
    CrossrefPubMedGoogle Scholar
  • 3 Report of the Ethics and Humanities subcommittee of the American Academy of Neurology. Palliative care in neurology. Neurology 1996; 46: 870-872
    PubMedGoogle Scholar
  • 4 Taylor LP, Besbris JM, Graf WD, Rubin MA, Cruz-Flores S, Epstein LG. Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, American Neurological Association, and Child Neurology Society. Clinical guidance in neuropalliative care: An AAN position statement. Neurology 2022; 98 (10) 409-416
    CrossrefPubMedGoogle Scholar
  • 5 Homewood H, Hewis J. ‘Scanxiety’: Content analysis of pre-MRI patient experience on Instagram. Radiography 2023; 29 (Suppl. 01) S68-S73
    CrossrefPubMedGoogle Scholar
  • 6 Brizzi K, Creutzfeldt CJ. Neuropalliative care: a practical guide for the neurologist. Semin Neurol 2018; 38 (05) 569-575
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Creutzfeldt CJ, Robinson MT, Holloway RG. Neurologists as primary palliative care providers: communication and practice approaches. Neurol Clin Pract 2016; 6 (01) 40-48
    CrossrefPubMedGoogle Scholar
  • 8 Triebel KL, Martin RC, Nabors LB, Marson DC. Medical decision-making capacity in patients with malignant glioma. Neurology 2009; 73 (24) 2086-2092
    CrossrefPubMedGoogle Scholar
  • 9 Fritz L, Zwinkels H, Koekkoek JAF. et al. Advance care planning in glioblastoma patients: development of a disease-specific ACP program. Support Care Cancer 2020; 28 (03) 1315-1324
    CrossrefPubMedGoogle Scholar
  • 10 Armour M, Del Toro CM, Kiran S, Raymer AM, Wallace SE. Aphasia and Other Communication Disorders Task Force of the Stroke Interdisciplinary Interest Group of the American Congress of Rehabilitation Medicine. Supportive Communication for Individuals with Aphasia. Arch Phys Med Rehabil 2021; 102 (07) 1437-1439
    CrossrefPubMedGoogle Scholar
  • 11 Diamond EL, Prigerson HG, Correa DC. et al. Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma. Neuro-oncol 2017; 19 (11) 1532-1541
    CrossrefPubMedGoogle Scholar
  • 12 Hui D, Maxwell JP, Paiva CE. Dealing with prognostic uncertainty: the role of prognostic models and websites for patients with advanced cancer. Curr Opin Support Palliat Care 2019; 13 (04) 360-368
    CrossrefPubMedGoogle Scholar
  • 13 Smith AK, White DB, Arnold RM. Uncertainty – the other side of prognosis. N Engl J Med 2013; 368 (26) 2448-2450
    CrossrefPubMedGoogle Scholar
  • 14 Habib AR, Chen R, Magnavita ES. et al. Prevalence and tolerance of prognostic uncertainty among thoracic oncologists. Oncologist 2021; 26 (08) e1480-e1482
    CrossrefPubMedGoogle Scholar
  • 15 LeBlanc TW, Temel JS, Helft PR. “How much time do i have?”: communicating prognosis in the era of exceptional responders. Am Soc Clin Oncol Educ Book 2018; 38: 787-794
    CrossrefPubMedGoogle Scholar
  • 16 Evans LR, Boyd EA, Malvar G. et al. Surrogate decision-makers' perspectives on discussing prognosis in the face of uncertainty. Am J Respir Crit Care Med 2009; 179 (01) 48-53
    CrossrefPubMedGoogle Scholar
  • 17 Gramling R, Stanek S, Han PKJ. et al. Distress due to prognostic uncertainty in palliative care: frequency, distribution, and outcomes among hospitalized patients with advanced cancer. J Palliat Med 2018; 21 (03) 315-321
    CrossrefPubMedGoogle Scholar
  • 18 Kruser JM, Nabozny MJ, Steffens NM. et al. “Best case/worst case”: qualitative evaluation of a novel communication tool for difficult in-the-moment surgical decisions. J Am Geriatr Soc 2015; 63 (09) 1805-1811
    CrossrefPubMedGoogle Scholar
  • 19 Holloway RG, Gramling R, Kelly AG. Estimating and communicating prognosis in advanced neurologic disease. Neurology 2013; 80 (08) 764-772
    CrossrefPubMedGoogle Scholar
  • 20 Kramer NM, Besbris J, Hudoba C. Education in neuropalliative care. Handb Clin Neurol 2023; 191: 259-272
    CrossrefPubMedGoogle Scholar
  • 21 Vital Talk Resources. Vital Talk. Accessed February 6, 2023 at: http://vitaltalk.org/resources/
    PubMedGoogle Scholar
  • 22 Communication Skills Curriculum. Center to Advance Palliative Care. Accessed February 6, 2023 at: https://www.capc.org/providers/courses/communication-skills-34/
    PubMedGoogle Scholar
  • 23 Tools for Clinicians. Ariadne Labs. Accessed February 6, 2023 at: https://www.ariadnelabs.org/serious-illness-care/for-clinicians/
    PubMedGoogle Scholar
  • 24 EPEC-Neurology. Education in Palliative and End-of-Life Care. Accessed February 6, 2023 at: https://www.inpcs.org/i4a/pages/index.cfm?pageid=3324
    PubMedGoogle Scholar
  • 25 Osoba D, Brada M, Prados MD, Yung WKA. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-oncol 2000; 2 (04) 221-228
    CrossrefPubMedGoogle Scholar
  • 26 Nelson S, Taylor LP. Headaches in brain tumor patients: primary or secondary?. Headache 2014; 54 (04) 776-785
    CrossrefPubMedGoogle Scholar
  • 27 Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol 2014; 117 (02) 217-224
    CrossrefPubMedGoogle Scholar
  • 28 Reblin M, Sahebjam S, Peeri NC, Martinez YC, Thompson Z, Egan KM. Medical cannabis use in glioma patients treated at a comprehensive cancer center in Florida. J Palliat Med 2019; 22 (10) 1202-1207
    CrossrefPubMedGoogle Scholar
  • 29 Porter AB, Liu H, Kohli S. et al. Efficacy of treatment with armodafinil for cancer-related fatigue in patients with high grade glioma. JAMA Oncol 2022; 8 (02) 259-267
    CrossrefPubMedGoogle Scholar
  • 30 Ruden E, Reardon DA, Coan AD. et al. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. J Clin Oncol 2011; 29 (21) 2918-2923
    CrossrefPubMedGoogle Scholar
  • 31 Khan F, Amatya B, Drummond K, Galea M. Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial. J Rehabil Med 2014; 46 (08) 754-760
    CrossrefPubMedGoogle Scholar
  • 32 Koekkoek JAF, van der Meer PB, Pace A. et al. Palliative care and end-of-life care in adults with malignant brain tumors. Neuro Oncol 2023; 25 (03) 447-456
    CrossrefPubMedGoogle Scholar
  • 33 Beevers Z, Hussain S, Boele FW, Rooney AG. Pharmacological treatment of depression in people with a primary brain tumour. Cochrane Database Syst Rev 2020; 7 (07) CD006932
    PubMedGoogle Scholar
  • 34 Zwinkels H, Dirven L, Vissers T. et al. Prevalence of changes in personality and behavior in adult glioma patients: a systematic review. Neurooncol Pract 2016; 3 (04) 222-231
    PubMedGoogle Scholar
  • 35 Bonm A, Taylor LP. Management of neurologic complications in patients with brain and spine tumors. Semin Neurol 2024; 44 (01) 53-63
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 van der Meer PB, Dirven L, Fiocco M. et al. First-line antiepileptic drug treatment in glioma patients with epilepsy: levetiracetam vs valproic acid. Epilepsia 2021; 62 (05) 1119-1129
    CrossrefPubMedGoogle Scholar
  • 37 Rudà R, Pellerino A, Franchino F. et al. Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. J Neurooncol 2018; 136 (01) 105-114
    CrossrefPubMedGoogle Scholar
  • 38 Coppola A, Zarabla A, Maialetti A. et al. Perampanel confirms to be effective and well-tolerated as an add-on treatment in patients with brain tumor-related epilepsy (PERADET study). Front Neurol 2020; 11 (592) 592
    CrossrefPubMedGoogle Scholar
  • 39 Edelstein K, Coate L, Massey C, Jewitt NC, Mason WP, Devins GM. Illness intrusiveness and subjective well-being in patients with glioblastoma. J Neurooncol 2016; 126 (01) 127-135
    CrossrefPubMedGoogle Scholar
  • 40 Kanter C, D'Agostino NM, Daniels M, Stone A, Edelstein K. Together and apart: providing psychosocial support for patients and families living with brain tumors. Support Care Cancer 2014; 22 (01) 43-52
    CrossrefPubMedGoogle Scholar
  • 41 Ford E, Catt S, Chalmers A, Fallowfield L. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-oncol 2012; 14 (04) 392-404
    CrossrefPubMedGoogle Scholar
  • 42 Nicklin E, Velikova G, Hulme C. et al. Long-term issues and supportive care needs of adolescent and young adult childhood brain tumour survivors and their caregivers: a systematic review. Psychooncology 2019; 28 (03) 477-487
    CrossrefPubMedGoogle Scholar
  • 43 Schmer C, Ward-Smith P, Latham S, Salacz M. When a family member has a malignant brain tumor: the caregiver perspective. J Neurosci Nurs 2008; 40 (02) 78-84
    CrossrefPubMedGoogle Scholar
  • 44 Sherwood PR, Given BA, Given CW. et al. Predictors of distress in caregivers of persons with a primary malignant brain tumor. Res Nurs Health 2006; 29 (02) 105-120
    CrossrefPubMedGoogle Scholar
  • 45 Schubart JR, Kinzie MB, Farace E. Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro-oncol 2008; 10 (01) 61-72
    CrossrefPubMedGoogle Scholar
  • 46 Bradley SE, Sherwood PR, Kuo J. et al. Perceptions of economic hardship and emotional health in a pilot sample of family caregivers. J Neurooncol 2009; 93 (03) 333-342
    CrossrefPubMedGoogle Scholar
  • 47 Soanes L, Hargrave D, Smith L, Gibson F. What are the experiences of the child with a brain tumour and their parents?. Eur J Oncol Nurs 2009; 13 (04) 255-261
    CrossrefPubMedGoogle Scholar
  • 48 Janda M, Eakin EG, Bailey L, Walker D, Troy K. Supportive care needs of people with brain tumours and their carers. Support Care Cancer 2006; 14 (11) 1094-1103
    CrossrefPubMedGoogle Scholar
  • 49 Talking with your Children about a Brain Tumor Diagnosis. American Brain Tumor Association. Accessed February 6, 2023 at: https://www.abta.org/wp-content/uploads/2018/03/caregivers-talking-to-your-children.pdf
    PubMedGoogle Scholar
  • 50 What Do I Tell the Kids? Cancer Support Community. Accessed February 6, 2023 at: https://www.cancersupportcommunity.org/sites/default/files/d7/document/fsac_what_do_i_tell_the_kids.pdf
    PubMedGoogle Scholar
  • 51 Diamond EL, Russell D, Kryza-Lacombe M. et al. Rates and risks for late referral to hospice in patients with primary malignant brain tumors. Neuro-oncol 2016; 18 (01) 78-86
    CrossrefPubMedGoogle Scholar
  • 52 Jain B, Dee EC, Jain U. et al. Trends in location of death for individuals with primary brain tumors in the United States. Neuro-oncol 2022; 24 (08) 1400-1401
    CrossrefPubMedGoogle Scholar
  • 53 McConigley R, Halkett G, Lobb E, Nowak A. Caring for someone with high-grade glioma: a time of rapid change for caregivers. Palliat Med 2010; 24 (05) 473-479
    CrossrefPubMedGoogle Scholar
  • 54 Sharma A, Besbris JM, Kramer NM. et al. Top ten tips palliative care clinicians should know about seizures at the end of life. J Palliat Med 2021; 24 (05) 760-766
    CrossrefPubMedGoogle Scholar